Regulation of the immune cell glycome in corneal injury
Regulation of the immune cell glycome in corneal injury
批准号:
10636875
负责人:
Pablo Argueso
金额:
$24.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2024-06-30
关键词:
Adaptive Immune SystemAdhesionsAffectAnimalsBindingBiological ProcessBlood CirculationBlood Group AntigensBone MarrowCD15 AntigensCell AdhesionCell Adhesion MoleculesCell Differentiation processCell Surface ReceptorsCell SurvivalCell physiologyCell surfaceCellsChimera organismChronicCicatrixCorneaCorneal InjuryDataDendritic CellsEndothelial CellsEndotheliumEnvironmentEnzymesEpitheliumExtracellular MatrixFibrosisGalactose Binding LectinGalectin 3GenerationsGlycocalyxGlycoconjugatesGlycoside HydrolasesHomeostasisHomingHumanHuman bodyImmuneImmune responseImmune systemImmunityImmunologic Deficiency SyndromesImmunologyImmunomodulatorsImpairmentInflammationInflammatoryInflammatory ResponseInnate Immune ResponseInnate Immune SystemLectinLeukocyte TraffickingLeukocytesLigandsMacrophageMononuclearMononuclear LeukocytesMonosaccharidesMotionMusOrganPathologicPathway interactionsPlayPolysaccharidesPopulationProcessProtein GlycosylationProteinsRegulationResearchRoleSelectinsSeriesSignal PathwaySiteSpecific qualifier valueStructureSurfaceTandem Repeat SequencesTestingTherapeuticTissuesVascular Endotheliumadaptive immune responsecell growthcell motilitycell typecrosslinkgain of functionglycosylationglycosyltransferasehealingimmune functionimmunoregulationloss of functionmonocyteneutrophilnoveloverexpressionpathogenprototypereceptorrepairedsialyl Lewis xtissue repairtraffickingtranslational impactwound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The immune system consists of billions of specialized cells in constant motion that function to maintain
homeostasis within the human body. Among them, monocytes are a population of circulating mononuclear
cells that can cross the vascular endothelium and move into sites if inflammation, where they participate in the
clearance of pathogens and the repairing of damaged tissue. The ability of certain monocytes to express
components of the extracellular matrix defines them as fibrocytes. This cell population has recently come
under intense scrutiny due to their pathological contribution to chronic inflammation and fibrosis in a variety of
organs, including the cornea.
Critical to the functions of the immune cells is the glycocalyx, a diverse mixture of glycans that functions as
the primary interface with the environment. Glycans play a vital role in both the innate and adaptive immune
systems by regulating signaling pathways and the activation of multiple cell types. The Lewis blood group
antigens are among the most important cell surface glycan determinants in immunology, as they promote
interaction with cell adhesion molecules expressed on the surface of endothelial cells. Because of its
significance to the immune reponse, there has been a need for the past few years to define how the glycome
of immune cells is regulated.
It has become increasingly clear that galectins play a critical role as modulators of the immune response.
They can interact with cell surface receptors to promote cell differentiation, affect cell growth and survival, and
modulate cell adhesion. We hypothesize that galectins play a dynamic role in the regulation of the immune
response by directing the immune cell glycome. The following specific aims will address this objective: (1) to
determine whether galectins influence the glycome of human mononuclear cells, (2) to investigate the role of
galectin-3 as a functional regulator of the sialyl Lewis X antigen in activated monocytes, and (3) to investigate
the role of galectin-3-dependent glycosylation in the trafficking and accumulation of corneal fibrocytes. It is
anticipated that this research will have significant translational impact given the impact of circulating fibrocytes
to wound healing and scar formation.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.addr.2021.114074
发表时间:
2022-01
期刊:
Advanced drug delivery reviews
影响因子:
16.1
作者:
[Argüeso P]
通讯作者:
Argüeso P
Galectins as Regulators of Corneal Inflammation.
半乳糖凝集素作为角膜炎症的调节剂。
DOI:
10.1016/j.cophys.2020.08.021
发表时间:
2021
期刊:
Current opinion in physiology
影响因子:
2.5
作者:
[Argüeso,Pablo]
通讯作者:
Argüeso,Pablo
DOI:
10.3389/fimmu.2021.729260
发表时间:
2021
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Argüeso P, Woodward AM, AbuSamra DB]
通讯作者:
AbuSamra DB
Regulation of the immune cell glycome in corneal injury
-
批准号:10602510
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2020
-
负责人:Pablo Argueso
-
依托单位:
Regulation of the immune cell glycome in corneal injury
-
批准号:10591019
-
项目类别:
-
资助金额:$27.8万
-
财政年份:2020
-
负责人:Pablo Argueso
-
依托单位:
Regulation of the immune cell glycome in corneal injury
-
批准号:10238839
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Pablo Argueso
-
依托单位:
N-Glycosylation and Ocular Surface Homeostasis
-
批准号:10197130
-
项目类别:
-
资助金额:$11.39万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-Glycosylation and Ocular Surface Homeostasis
-
批准号:10578975
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-Glycosylation and Ocular Surface Homeostasis
-
批准号:9973535
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-glycosylation and ocular surface homeostasis
-
批准号:9533581
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-glycosylation and ocular surface homeostasis
-
批准号:9196100
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-Glycosylation and Ocular Surface Homeostasis
-
批准号:10445276
-
项目类别:
-
资助金额:$43.17万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
CD147 and Corneal Wound Repair
-
批准号:8816764
-
项目类别:
-
资助金额:$50.64万
-
财政年份:2015
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:6795401
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:7117212
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:8197267
-
项目类别:
-
资助金额:$46.56万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:7784789
-
项目类别:
-
资助金额:$48.9万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:6670594
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:6928499
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:8007363
-
项目类别:
-
资助金额:$46.7万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:7281183
-
项目类别:
-
资助金额:$33.31万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:8578100
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:8374122
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
海外基金